1. 1 OncoCollect ™ Collection of Real World Data in Oncology Dr Ramesh B V Nimmagadda Director, Medical Oncology Apollo Speciality Cancer hospital, Chennai & Managing Trustee Ramesh Nimmagadda Cancer Foundation

2. 2 1) E M R 2) Clinical Data Collection for Analysis Are two different things

3. 3 THE HARD TRUTH IN 2015

4. 4 Medical Oncologists- USA vs. India New Cases 1.6 Million / Yr 1 Million / Yr

5. 5 Workload standard recommendations Canada  Workload for MO in teaching RCCs be set at 158 new patients per year.  Workload for MO in nonteaching RCCs be set at 173 new patients per year.  Annual workload increase would require an additional medical oncologist.  New workload standards be implemented over a three year period starting in fiscal 1999/2000.  Additional data be gathered periodically to determine the workload standard and manpower requirements due to changing treatments.

6. 6 MO needed estimations for India 170 new patients per MO we need 5882 340 new patients per MO we need 2941 510 new patients per MO we need 1960 680 new patients per MO we need 1470 850 new patients per MO we need 1176 1 Million new and 1.8 million prevalent cases

7. 7 1) E M R 2) Clinical Data Collection for Analysis Are two different things and both are needed but should be kept separate, in India for sure.

8. 8 Breast Cancer 1999-2008

9. Early Breast Cancer 99-08 Lymph Node

11. 11 OncoCollect ™

12. 12 Localized Database, Enabled for pooling in the Cloud without Patient Identity Information. - Encrypted patient identity data - Flexible Dynamic Data Elements, screens on the fly - Responsive Design - Medical Coding - Microsoft.NET Platform - SQL Server 2012 - Export to excel and Cloud without Patient Identity Parameters - Built-in Formulas to facilitate Analysis, Statistics and follow ups - Graphical representation of Events What does it Do...? www.rncf.in

13. 13 OncoCollect ™ Institution - A Institution - B---- BLADDER CA STUDY---- COLON CA STUDY Institution - C--- BREAST CA STUDY---- COLON CA STUDY Institution - D--- BREAST CA STUDY---- BLADDER CA STUDY Master (Live Update) Studies ABCD -Principal Investigator will have access to download Pooled data of his group’s study -Data pooled without patient / Consultant Identities www.rncf.in

14. 14 Main Objective  Establish a common platform for data collection in oncology for Treatment and outcomes across the country.  Enable individuals and institutions to form groups and pool data for analysis.  Enable easy analysis of this data by both individuals and the institutions, to constantly refine their treatments to suit their local conditions. Ramesh Nimmagadda Cancer Foundation www.rncf.in

15. 15 Ramesh Nimmagadda Cancer Foundation Vision To Create a repository of Indian data on Treatment and Outcomes to formulate India-Specific treatment guidelines for cancer Based on Indian Data www.rncf.in

16. 16 OncoCollect ™ Installed so far.. 1)Apollo Specialty Cancer Hospital, Chennai 2)Mahavir Cancer Sansthan, Patna 3)Tata Medical Centre, Kolkata 4)Basavtharakam Indo American Cancer Hospital & Research Institute, Hyderabad 5)Rajiv Gandhi Cancer Institute & Research Centre, New Delhi 6)Chennai Breast Centre, Chennai 7)G K N M Hospital, Coimbatore National Cancer Grid Accepted Ramesh Nimmagadda Cancer Foundation www.rncf.in Approximately 100000 New patients / Year are seen in these centers www.rncf.in

17. 17 1) 1200 Breast Cancer patient data from Chennai Breast Centre, Chennai 2) 750 Lymphoma patient data from Tata Medical Centre, Kolkata 3) 165 Triple –Ve Breast Cancer patient data from Chennai Breast Centre, Chennai To be presented at ISMPO ISO Biennial Conference 6-8 Nov 2015 in Mumbai Ramesh Nimmagadda Cancer Foundation www.rncf.in

18. 18 Ramesh Nimmagadda Cancer Foundation OncoCollect ™ is owned by RNCF OncoCollect ™ is provided free of cost to all involved with treatment of Cancer in India and willing to collect Clinical Data. www.rncf.in

19. 19 Thank You

20. 20

21. Establishing Common Minimum Data Collection in the Country UHID Sex District State Postal Code Age at Diagnosis Second Oncology Consultation Site Of Primary Date Of Diagnosis Histology M Metastases pT TumourSize pN LymphNodes Pathalogical Stage cT Tumor Size cN Lymph Nodes Clinical Stage Consumed from the EMR Diagnosis & Staging Surgery Surgical Procedure Date Of Surgery Radio Therapy R/T Site R/T Start Date R/T End Date 1st line Systemic Therapy 1st Line Drug Group 1st Line Hormone Therapy 1st Line Systemic Therapy Type 1st Recurrence Pattern Status Recurrence Treatment Outcome www.rncf.in

22. Breast Cancer 1999-2008